Intestinal Cell News Volume 9.38 | Oct 13 2023

    0
    9







    2023-10-13 | ICN 9.38


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.38 – 13 October, 2023
    TOP STORY

    Claudin-2 Protects from Colitis-Associated Cancer by Promoting Colitis-Associated Mucosal Healing

    Investigators demonstrated a novel role of claudin-2 in promoting mucosal healing in inflammatory bowel disease patients and thus regulating vulnerability to colitis severity and colitis-associated cancer, which can be exploited for improved clinical management.
    [Journal Of Clinical Investigation]

    AbstractGraphical Abstract
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Inhibition of Mitochondrial Fission Activates Glycogen Synthesis to Support Cell Survival in Colon Cancer

    Researchers investigated the role of Drp1 in regulating glycogen metabolism in colon cancer. Knockdown of Drp1 decreases mitochondrial respiration without increasing glycolysis.
    [Cell Death & Disease]

    Full Article

    The ATF2/miR-3913-5p/CREB5 Axis Is Involved in the Cell Proliferation and Metastasis of Colorectal Cancer

    Scientists determined that miR-3913-5p was downregulated in colorectal cancer (CRC) cell lines and CRC tissues. Exogenous miR-3913-5p expression weakened the CRC cell’s growth, migration, and invasion.
    [Communications Biology]

    Full Article

    Identification of GUCA2A and COL3A1 As Prognostic Biomarkers in Colorectal Cancer by Integrating Analysis of RNA-Seq Data and qRT-PCR Validation

    Researchers performed an integrated analysis of four RNA-Seq data sets and TCGA datasets in this study to find novel biomarkers for diagnostic, prediction, and as potential therapeutic for this malignancy, as well as to determine the molecular mechanisms of colorectal cancer carcinogenesis.
    [Scientific Reports]

    Full Article

    Walnut Protein Peptides Ameliorate DSS-Induced Ulcerative Colitis Damage in Mice: An In Silico Analysis and In Vivo Investigation

    In vivo studies have shown that walnut protein peptides improve intestinal mucosal barrier dysfunction and reduce inflammation by inhibiting activation of the TLR4-MAPK pathway.
    [Journal Of Agricultural And Food Chemistry]

    AbstractGraphical Abstract

    Wheat Germ-Derived Peptide Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice

    Investigators explored the protective properties and potential mechanisms of wheat-germ-derived peptide APEPEPAF against ulcerative colitis. Colitis mice induced by dextran sulfate sodium were used as the animal model.
    [Journal Of Agricultural And Food Chemistry]

    AbstractGraphical Abstract

    Identification of a Functional Peptide of a Probiotic Bacterium-Derived Protein for the Sustained Effect on Preventing Colitis

    Scientists applied structure-functional analysis to define the functional peptide of p40 that modulated the epigenetic program in intestinal epithelial cells for sustained prevention of colitis.
    [Gut Microbes]

    Full Article

    Mimicry of Microbially-Derived Butyrate Reveals Templates for Potent Intestinal Epithelial HIF Stabilizers

    Investigators explored metabolite mimicry as an attractive strategy for the biological response to hypoxia-inducible factors (HIF). They discovered that 4-mercapto butyrate stabilized HIF more potently and had a longer biological half-life than butyrate in intestinal epithelial cells.
    [Gut Microbes]

    Full Article

    Anti-Inflammatory and Anti-Oxidant Impacts of Lentinan Combined with Probiotics in Ulcerative Colitis

    An HT-29 cell model of colitis was established by dextran sulfate sodium stimulation and cultured with lentinan and/or probiotics to examine cell proliferation and apoptosis.
    [Molecular Biotechnology]

    AbstractGraphical Abstract
    Your Online Resource for Cell Visualization. View StainsFile.
    REVIEWS

    Interaction Between Mitochondria and Microbiota Modulating Cellular Metabolism in Inflammatory Bowel Disease

    The authors stratify previously reported experimental and clinical observations of the role of mitochondria and intestinal microbiota in IBD.
    [Journal Of Molecular Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

    Sanofi and Teva Pharmaceuticals announced a collaboration to co-develop and co-commercialize asset TEV’574, currently in Phase IIb clinical trials for the treatment of Ulcerative Colitis and Crohn’s Disease, two types of inflammatory bowel disease.
    [Sanofi]

    Press Release
    FEATURED EVENT

    AACR-KCA Joint Conference on Precision Medicine in Cancer

    November 15 – 17, 2023
    Seoul, Korea

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Inflammatory Bowel Disease

    Cedars Sinai Medical Center – Los Angeles, California, United States

    Assistant/Associate Professor – Colorectal Surgery

    Emory University – Atlanta, Georgia, United States

    Postdoctoral Scholar – Innate Immunity in the Pathogenesis of Inflammatory Intestinal Diseases

    University of Calgary – St. Albert, Alberta, Canada

    Director – Gastroenterology

    Boston Univeristy – Boston, Massachusetts, United States

    Associate Professor – Physiology

    The University of Tennessee – Memphis, Tennessee, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter